May 16, 2017

CURRICULUM VITAE

JOHN S. SCHIEFFELIN, MD

Home Address: 3825 Chestnut StreetNew Orleans, LA 70115(504) 220-1579

Office Address: Tulane University School of MedicineDepartments of Pediatrics and Internal Medicine Sections of Infectious Disease1430 Tulane Ave Box 8408New Orleans, LA 70112Phone: 504/988-5117Fax: 504/988-2613Email: jschieff@tulane.edu

Social Security #: by request

Personal Data: born: Walnut Creek, California, 6/14/1970spouse: Catherine Schieffelinchildren: Anna, born 12/21/2000

Caroline, born 2/23/2003Samuel, born 8/30/2005

Education: 1988 - 1992A.B. Cornell University (Biology Honors Major)

1993 - 1995 MSPH Tulane University School of Public Health and Tropical Medicine

1997 - 2001M.D. Tulane University School of Medicine

Postgraduate Training and Fellowship Appointments:

2001 – 2002 Intern in Internal Medicine and Pediatrics, Tulane University School of Medicine, New Orleans, LA

2002 - 2005 Resident in Internal Medicine and Pediatrics, Tulane University School of Medicine,

New Orleans, LA

2005 - 2009 Fellow in Adult and Pediatric Infectious Disease, Louisiana State University Health Sciences Center and Tulane University School of Medicine, New Orleans, LA

Academic Appointments:

2009 - Assistant Professor of Clinical Medicine, Departments of Internal Medicine and Pediatrics, Sections of Infectious Diseases, Tulane University School of Medicine

2014 - Adjunct Faculty, Department of Tropical Medicine, Tulane University School of Public Health and Tropical Medicine

Medical School and Administrative Appointments:

2012 - Pediatric Infectious Disease Fellowship Director

Hospital Affiliations:

2009 - Tulane University Medical Center, New Orleans, LA

2009 - University Medical Center, New Orleans, LA

2016 - Ochsner Hospital and Clinic, New Orleans, LA

Specialty Certification:

2006 Diplomate, American Board of Internal Medicine #267407 (valid through 2016)

2007 Diplomate, American Board of Pediatrics #090341 (valid through

2017)2010 Diplomate, Infectious Disease Subspecialty,

American Board of Internal Medicine (valid through 2020)

2011 Diplomate, Infectious Disease Subspecialty, American Board of Pediatrics (valid through 2021)

Additional Education: 2016 CHEST: Ultasonography Essentials in Critical

Care

Licensure: 2002 Diplomate, National Board of Medical

Examiners 2002 Louisiana MD.0256542001 ACLS, BLS

Awards, Honors, and Memberships in Honor Societies:

1992 Cum Laude, Cornell University2015 New Orleans City Business Healthcare Hero

Membership in Professional and Scientific Societies:

2001 Member, American Academy of Pediatrics2010 Fellow, American Academy of Pediatrics2003 Member, American College of Physicians-

American Society of Internal Medicine2005 Member, Infectious Disease Society of America2007 Member, Pediatric Infectious Disease Society2008 Member, American Society of Tropical

Medicine and Hygiene

Scientific Journal Ad-hoc Reviewer

Virology JournalPLoS OnePLoS Neglected Tropical DiseasesThe LancetJournal of the American Society of Tropical Medicine and HygieneUpToDate

Editorial Positions

2016 – Present Editorial Board, Journal of Pediatric Infectious Diseases

Reviewer:

2016 – Present Abstract ReviewerPediatric Academic Societies

Scientific Grant Review Sections

2017 – Present College of Reviewers, Canadian Institute for Health Research

Mentorship Activities: Graduate Student Committees

2010 – 2013 Mark Rider, Member of Doctoral Committee, Department of Tropical Medicine, School of Public Health and Tropical Medicine

2010 – 2014 Lindsey Bazzone, Member of Doctoral Committee, Physician Scientist Training Program, Tulane University

2013 – 2015 Nell Bond, Member of Doctoral Committee Department of Tropical Medicine, School of Public Health and Tropical Medicine

2013 – 2015 Benjamin Bradley, Member of Doctoral Committee, Physician Scientist Training Program, Tulane University

2012 – 2016 Rachel Yenni, Member of Doctoral Committee, BioMedical Science Training Program, Department of Microbiology, Tulane University

2013 – 2015 Matthew Boisen, Member of Doctoral Committee, BioMedical Science Training Program, Department of Microbiology, Tulane University

2014 – Present Brandon Beddingfield, Member of Doctoral Committee, BioMedical Science Training Program, Department of Microbiology, Tulane University

2016 – 2017 Ania Kawiecki, Member of Masters Committee, Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University

Mentor for Post-Doctoral Scholars

2014 – 2017 Sarah Labuda2016 - Brigid O-Brien2017 - Monika Dietrich

03/01/14–02/Past Research Funding

Generation of anti-Dengue Virus Neutralizing Human Monoclonal Antibodies Using Reporter Virus ParticlesSource: Integral Molecular Direct Costs: $65,000/yearAugust 1, 2011 to July 31, 2012

Neutralization and Enhancement of Dengue Virus by Human Monoclonal Antibodies Source: South Louisiana Institute for Infectious Disease Research, Postdoctoral Support Award , $50,000. Role: Principal InvestigatorJuly 2008 – June 2010

Preclinical development of recombinant antigen Lassa fever diagnostics -Sub-contract to Dr. James Robinson (1U01AI082119-01)Source: NIH Direct Costs: $390,831/yearRole: Co-InvestigatorApril 1, 2009 to March 30, 2014

Host Genetic Factors in Resistance to Lassa Hemorrhagic Fever (NIAID-DAIT-NIH2009061)Source: NIH Direct Costs: $64,852/yearRole: Co-InvestigatorJune 1, 2010 to December 31, 2014

Mentoring Translational Researchers in Louisiana (P20RR021970-06)Project 5 Principal Investigator, Identification of Protective and Pathogenic Human B Cell Epitopes in Dengue VirusSource: NIH-NCRR Direct Costs: $131,000/yearAugust 1, 2010 to June 30, 2015

Roles of Protective and Pathogenic B Cell epitopes in Human Lassa Fever (BAA-NIAID-DAIT-NIHAI2008031)Source: NIH Direct Costs: $265,628/yearRole: Co-InvestigatorSeptember 1, 2010 to August 30, 2015

Roles of Protective and Pathogenic B Cell epitopes in Human Lassa Fever - Sub-contract to Dr. Robert Garry (BAA-NIAID-DAIT-NIHAI2008031)Source: NIH Direct Costs: $864,475/yearRole: Co-InvestigatorSeptember 1, 2010 to August 30, 2015

Late Stage Development Toward Commercialization of Multi-Lineage Point-of-Care Lassa Fever Diagnostics (1R44AI115754)Source: NIAID Direct Costs: $927,590 / yearRole: Co-InvestigatorFebruary 5, 2015 to January 31, 2017

Active Research Funding

Antibody Immunotherapeutics for biodefense against Lassa virus (1R01AI104621) Source: NIAID Direct Costs: $938,364 / yearRole: Co-Investigator April 1, 2013 to March 31, 2018

Consortium for Immunotherapeutics against viral hemorrhagic fevers (1U19AI109762)Source: NIAID Direct Costs: $692,230 / yearRole: Co-InvestigatorMarch 1, 2014 to February 28, 2019

Identification and Validation of Novel Human T Cell Epitopes in Humans – Sub-contract to Dr. Robert Garry (272201400048C)Source: NIAID Direct Costs: $1,420,165 / yearRole: Co-InvestigatorSeptember 30, 2014 to September 29, 2019

International Collaboration in Infectious Disease Research on Lassa Fever and Ebola Virus Disease (1U19AI115589)Source: NIAID Direct Costs: $215,760 / yearRole: Project 2 Principle InvestigatorFebruary 22, 2015 to January 31, 2020

Building Interdisciplinary Research Careers in Women’s Health (5K12HD043451-14)Source: National Institutes of Health Direct Costs: $499,998 / yearRole: Project Lead (The Role of Acute Cardiovascular Disease and Gender in Lassa Fever)September 1, 2015 to July 31, 2017

Partnership for Research in Emerging Viral Infections – Sierra Leone (D71TW010411)Source: National Institutes of Health Direct Costs: $16,056Role: co-Principal InvestigatorSeptember 22, 2016 to August 31, 2017

Clinical Sequelae and Urogenital Viral Dynamics in Survivors of Ebola Virus Disease (1R01AI123535)Source: National Institutes of Health Direct Costs: $574,922/yearRole: multi-Principal InvestigatorMarch 3, 2017 to February 28, 2022

Other National and Regional Academic Activities:

2017- Test-item writer and editor for American Academy of Pediatrics PREP Subspecialty Editorial Board

Academic Committees at Tulane University (past 5 years):

Hospital: 2009-2014 Tulane Hospital Antibiotic Subcommittee2010-Present Tulane Hospital Infection Control Committee2013-Present University Medical Center of New Orleans Infection

Control Committee2013-Present Tulane Hospital Pharmacy and Therapeutics Committee2015-Present University Medical Center of New Orleans Research

Committee

Medical School: 2009-Present Tulane University Biomedical Institutional Review Board2012-Present Pediatric Infectious Disease Fellowship Director

University: 2015-Present Tulane University Student Conduct Hearing Board Member

National and International Committees

2014 - Present Pediatric Academic Societies Program Committee Member2014 – Present WHO, Global Outbreak, Alert and Response Network2015 – Present WHO, Emerging Disease Clinical Alert and Response Network

Consultant Positions

July-August, 2014 World Health Organization: Global Outbreak, Alert and Response Network. Clinical expert for Ebola Outbreak response, Sierra Leone

Major Clinical and Teaching Responsibilities:

Attending - Adult Infectious Disease Consult Service (1.5 month/year)Attending - Pediatric Infectious Disease Consult Service (1.5 month/year)Attending - Infectious Disease Clinic, Tulane University Medical CenterLecturer – Tropical Medicine, Tulane School of Public Health and Tropical MedicineParticipant – Clinical pediatric conferences and grand rounds, Tulane Medical Center

Invited Lectures

Antibody Dependent Enhancement: Implications for Vaccine Development, Louisiana State University Health Sciences Center, Department of Microbiology, Immunology and Parasitology Fall 2010 Seminar Series, December, 2010

New Group B Strep Guidelines and Immunization Update, Tulane University School of Medicine, Department of Pediatrics and the Tulane Center for Continuing Education, Saturday Pediatric Series, June 11, 2011

Update on MRSA Guidelines and Pediatric Vaccines, Tulane University School of Medicine, Department of Pediatrics and the Tulane Center for Continuing Education, Saturday Pediatric Series, June 16, 2012

Viral Hemorrhagic Fevers: Overcoming Diagnostic and Management Challenges, New Orleans Citywide Infectious Disease Meeting, December 6, 2013

Treating Ebola in (Very) Resource Limited Settings, New Orleans Citywide Infectious Disease Meeting, September 12, 2014

Treating Ebola in (VERY) Resource Limited Settings, Tulane Department of Tropical Medicine Special Seminar, September 15, 2014

Ebola: Lessons Learned From An Outbreak, Tulane University Department of Medicine Grand Rounds, October 1, 2014

A Decade of VHF Research at Tulane University, Tulane University Presidential Symposium, Translational Research in Infectious Diseases: From Microbes to Man, March 11-13, 2015

Ebola Prevention and Treatment, 31st Annual Clinical Virology Symposium, April 26-29, 2015, Daytona Beach, FL

A Decade of VHF Research at Tulane University, Colorado Allergy and Annual Society, September 8, 2015, Broncos Stadium, Denver CO

Immunopathogenesis of Ebola Virus Disease, National Jewish Hospital, Department of Medicine, Section of Allergy and Immunology Grand Rounds, September 9, 2015, Denver, CO

Viral Hemorrhagic Fever Research in Sierra Leone: At a Crossroads. Vanderbilt University, Transinstitutional Programs Seminar Series, April 6, 2017, Nashville, TN

Lassa Fever Research In Sierra Leone. Vanderbilt University, Vanderbilt Global Health Institute Seminar, April 7, 2017, Nashville, TN

Viral Hemorrhagic Fever Research in Sierra Leone. Vanderbilt University, Pediatric Residency Noon Conference, April 7, 2017, Nashville, TN

Bibliography

Original Manuscripts, letters and commentaries:

1. Peacock D, Schieffelin J, Heinrich P et al. A 48 year old man with a non-healing wound. J La State Med Soc. 2007;159:186-189. PMID: 17987954

2. Schieffelin JS, Costin JM, Nicholson O, Orgeron NM, Fontaine KA, Isern S, Michael SF, Robinson JE. Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient. Virol J. 2010 Feb 4;7(1):28. PMID: 20132551

3. Grove JN, Branco LM, Boisen ML, Muncy IJ, Henderson LA, Schieffelin JS, Robinson JE, Bangura JJ, Fonnie M, Schoepp RJ, Hensley LE, Seisay A, Fair JN, Garry RF. Capacity building permitting comprehensive monitoring of a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive outcome: case report. Virol J. 2011 Jun 20;8(1):314. PMID: 21689444

4. Branco LM, Boisen ML, Andersen KG, Grove JN, Moses LM, Muncy IJ, Henderson LA, Schieffelin JS, Robinson JE, Bangura JJ, Grant DS, Raabe VN, Fonnie M, Sabeti PC, Garry RF. Lassa Hemorrhagic Fever in a Late Term Pregnancy from Northern Sierra Leone with a Positive Maternal Outcome: Case Report. Virol J. 2011 Aug 15;8(1):404. PMID: 21843352

5. Costin JM, Zaitseva E, Kahle KM, Nicholson CO, Rowe DK, Graham AS, Bazzone LE, Hogancamp G, Sierra MF, Fong RH, Yang ST, Lin L, Robinson JE, Doranz BJ, Chernomordik LV, Michael SF, Schieffelin JS, Isern S. Mechanistic study of broadly neutralizing human monoclonal antibodies against dengue virus that target the fusion loop. J Virol. 2013 Jan;87(1):52. PMID 23077306

6. Bond N, Schieffelin JS, Moses L, Bennett A, Bausch D. A historical look at the first reported cases of lassa fever: IgG antibodies 40 years after acute infection. Amer J Tropic Med Hyg. Am J Trop Med Hyg. 2013 Feb;88(2):241. PMID 23390223

7. Schieffelin JS, Williams PL, Djokic D, Anderson JP, Nachman S, Oleske JM, Seage GR, Van Dyke RB. Central nervous system vasculopathy in Human Immunodeficiency Virus-infected children enrolled in the Pediatric AIDS Clinical Trials Group 219/219C study. J Pediat Infect Dis. 2013; 2(1):50. PMID: 26619442

8. Schieffelin JS, Torrellas M, Lartchenko S, Gill F, Garcia-Diaz J, McGoey R. How natural disasters change natural patterns: coccidioidomycosis in New Orleans. J La State Med Soc. 2013; 165(3):145. PMID 24015428

9. Schieffelin JS, Garcia-Diaz JB, Loss GE, Beckman EN, Keller RA, Staffeld-Coit C, Garces JC, Pankey GA. Phaeohyphmycosis Fungal Infections in Solid Organ Transplant Recipients: Clinical Presentation, Pathology and Treatment. Transplant Infect Dis. 2014 Mar 17. PMID 24628809

10. Shaffer JG, Grant DS, Schieffelin JS, Boisen ML, Goba A, Hartnett JN, Levy DC, Yenni RE, Moses LM, Fullah M, Momoh M, Fonnie M, Fonnie R, Kanneh L, Koroma VJ, Kargbo K, Ottomassathien D, Muncy IJ, Jones AB, Illick MM, Kulakosky PC, Haislip AM, Bishop CM, Elliot DH, Brown BL, Zhu H, Hastie KM, Andersen KG, Gire SK, Tabrizi S, Tariyal R, Stremlau M, Matschiner A, Sampey DB, Spence JS, Cross RW, Geisbert JB, Folarin OA, Happi CT, Pitts KR, Geske FJ, Geisbert TW, Saphire EO, Robinson JE, Wilson RB, Sabeti PC, Henderson LA, Khan SH, Bausch DG, Branco LM, Garry RF. Lassa Fever in Post-Conflict Sierra Leone. PLOS NTD. 2014; 8(3):e2748. PMID 24651047

11. Gire SK, Goba A, Andersen KG, Sealfon RSG, Park DJ, Kanneh L, Jalloh S, Momoh M, Fullah M, Dudas G, Wohl S, Moses LM, Yozwiak NL, Winnicki S, Matranga CB, Malboeuf CM, Qu J, Gladden AD, Schaffner SF, Yang X, Jiang PP, Kekoui M, Colubri A, Coomber MR, Fonnie M, Moigboi A, Gbakie M, Kamara FK, Tucker V, Konuwa

E, Saffa S, Sellu J, Jalloh AA, Kovoma A, Koninga J, Mustapha I, Kargbo K, Foday M, Yillah M, Kanneh F, Robert W, Massally JLB, Chapman SB, Bochicchio J, Murphy C, Nusbaum C, Young S, Birren BW, Grant DS, Schieffelin JS, Lander ES, Happi C, Gevao SM, Gnirke A, Rambaut A, Garry RF, Khan SH, Sabeti PC. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science. 2014 Sep 12;345(6202):1369-72. PMID:25214632

12. Fowler RA, Fletcher T, Fischer Ii WA, Lamontagne F, Jacob S, Brett-Major D, Lawler JV, Jacquerioz FA, Houlihan C, O'Dempsey T, Ferri M, Adachi T, Lamah MC, Bah EI, Mayet T, Schieffelin J, McLellan SL, Senga M, Kato Y, Clement C, Mardel S, Vallenas Bejar De Villar RC, Shindo N, Bausch D. Caring for Critically Ill Patients with Ebola Virus Disease: Perspectives from West Africa. Am J Respir Crit Care Med. 2014 Aug 28. PMID: 25166884

13. Bausch DG, Bangura J, Garry RF, Goba A, Grant DS, Jacquerioz FA, McLellan SL, Jalloh S, Moses LM, Schieffelin JS. A tribute to Sheik Humarr Khan and all the healthcare workers in West Africa who have sacrificed in the fight against Ebola virus disease: Mae we hush. Antiviral Res. 2014 Sep 6;111C:33-35. PMID: 25196533

14. Jacob ST, Crozier I, Schieffelin JS, Colebunders R. Priorities for Ebola virus disease response in West Africa. Lancet. 2014 Sep 24. PMID 25262343

15. Schieffelin JS, Shaffer JG, Goba A, Gbakie M, Gire SK, Colubri A, Sealfon RS, Kanneh L, Moigboi A, Momoh M, Fullah M, Moses LM, Brown BL, Andersen KG, Winnicki S, Schaffner SF, Park DJ, Yozwiak NL, Jiang PP, Kargbo D, Jalloh S, Fonnie M, Sinnah V, French I, Kovoma A, Kamara FK, Tucker V, Konuwa E, Sellu J, Mustapha I, Foday M, Yillah M, Kanneh F, Saffa S, Massally JL, Boisen ML, Branco LM, Vandi MA, Grant DS, Happi C, Gevao SM, Fletcher TE, Fowler RA, Bausch DG, Sabeti PC, Khan SH, Garry RF; the KGH Lassa Fever Program, the Viral Hemorrhagic Fever Consortium, and the WHO Clinical Response Team. Clinical Illness and Outcomes in Patients with Ebola in Sierra Leone. N Engl J Med. 2014 Oct29. PMID 25353969

16. Roth PJ, Grant DS, Ngegbai AS, Schieffelin J, McClelland RS, Jarrett OD.Factors Associated with Mortality in Febrile Patients in a Government Referral Hospital in the Kenema District of Sierra Leone. Am J Trop Med Hyg. 2014 Nov 17. pii: 14-0418. PMID: 25404077

17. Kuhn JH, Andersen KG, Baize S, Bào Y, Bavari S, Berthet N, Blinkova O, Brister JR, Clawson AN, Fair J, Gabriel M, Garry RF, Gire SK, Goba A, Gonzalez JP, Günther S, Happi CT, Jahrling PB, Kapetshi

J, Kobinger G, Kugelman JR, Leroy EM, Maganga GD, Mbala PK, Moses LM, Muyembe-Tamfum JJ, N'Faly M, Nichol ST, Omilabu SA, Palacios G, Park DJ, Paweska JT, Radoshitzky SR, Rossi CA, Sabeti PC, Schieffelin JS, Schoepp RJ, Sealfon R, Swanepoel R, Towner JS, Wada J, Wauquier N, Yozwiak NL, Formenty P. Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014. Viruses 2014;6(11):4760-99. PMID: 25421896

18. Jiang C, Schieffelin JS, Li J, Sun W. Dengue Fever: a new challenge for China? Glob Health Action. 2014 Dec 18;7:26421. PMID: 25527249

19. Schieffelin JS, Xu T, Sun W. Does screening keep Ebola out of USA? Trop Med Surg. 2014:2. PMID: 25685826

20. Iacono GL, Cunningham AA, Fichet-Calvet E, Garry RF, Grant DS, Khan SH, Leach M, Moses LM, Schieffelin JS, Shaffer JG, Webb CT, Wood JLN. Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever. PLOS NTD 2015; 9(1): e3398. PMID:25569707

21. Brett-Major DM, Jacob ST, Jacquerioz FA, Risi GF, Fischer WA 2nd, Kato Y, Houlihan CF, Crozier I, Bosa HK, Lawler JV, Adachi T, Hurley SK, Berry LE, Carlson JC, Button TC, McLellan SL, Shea BJ, Kuniyoshi GG, Ferri M, Murthy SG, Petrosillo N, Lamontagne F, Porembka DT, Schieffelin JS, Rubinson L, O'Dempsey T, Donovan SM, Bausch DG, Fowler RA, Fletcher TE. Being ready to treat ebola virus disease patients. Am J Trop Med Hyg. 2015;92(2):233-7. PMID: 25510724

22. Boisen ML, Schieffelin JS, Goba A, Oottamasathien D, Jones AB, Shaffer JG, Hastie KM, Hartnett JN, Momoh M, Fullah M, Gabiki M, Safa S, Zandonatti M, Fusco M, Bornholdt Z, Abelson D, Gire SK, Andersen KG, Tariyal R, Stremlau M, Cross RW, Geisbert JB, Pitts KR, Geisbert TW, Kulakoski P, Wilson RB, Henderson L, Sabeti PC, Grant DS, Garry RF, Saphire EO, Branco LM, Khan SH. Multiple circulating infections can mimic the early stages of viral hemorrhagic fevers and possible human exposure to filoviruses in sierra leone prior to the 2014 outbreak. Viral Immunol. 2015;28(1):19-31. PMID: 25531344

23. Park DJ, Dudas G, Wohl S, Goba A, Whitmer SL, Andersen KG, Sealfon RS, Ladner JT, Kugelman JR, Matranga CB, Winnicki SM, Qu J, Gire SK, Gladden-Young A, Jalloh S, Nosamiefan D, Yozwiak NL, Moses LM, Jiang PP, Lin AE, Schaffner SF, Bird B, Towner J, Mamoh M, Gbakie M, Kanneh L, Kargbo D, Massally JL, Kamara FK, Konuwa E, Sellu J, Jalloh AA, Mustapha I, Foday M, Yillah M, Erickson BR, Sealy T, Blau D, Paddock C, Brault A, Amman B, Basile J, Bearden S,

Belser J, Bergeron E, Campbell S, Chakrabarti A, Dodd K, Flint M, Gibbons A, Goodman C, Klena J, McMullan L, Morgan L, Russell B, Salzer J, Sanchez A, Wang D, Jungreis I, Tomkins-Tinch C, Kislyuk A, Lin MF, Chapman S, MacInnis B, Matthews A, Bochicchio J, Hensley LE, Kuhn JH, Nusbaum C, Schieffelin JS, Birren BW, Forget M, Nichol ST, Palacios GF, Ndiaye D, Happi C, Gevao SM, Vandi MA, Kargbo B, Holmes EC, Bedford T, Gnirke A, Ströher U, Rambaut A, Garry RF, Sabeti PC. Ebola Virus Epidemiology, Transmission, and Evolution during Seven Months in Sierra Leone. Cell. 2015;161(7):1516-26. PMID: 26091036

24. Boisen ML, Oottamasathien D, Jones AB, Millett MM, Nelson DS, Bornholdt ZA, Fusco ML, Abelson DM, Oda SI, Hartnett JN, Rowland MM, Heinrich ML, Akdag M, Goba A, Momoh M, Fullah M, Baimba F, Gbakie M, Safa S, Fonnie R, Kanneh L, Cross RW, Geisbert JB, Geisbert TW, Kulakosky PC, Grant DS, Shaffer JG, Schieffelin JS, Wilson RB, Saphire EO, Branco LM, Garry RF, Khan SH, Pitts KR; Viral Hemorrhagic Fever Consortium. Development of Prototype Filovirus Recombinant Antigen Immunoassays. J Infect Dis. 2015 Jul 30. PMID: 26232440

25. Schieffelin JS. Treatment of Arenavirus Infections. Curr Treat Options Infect Dis. 2015 July 24.

26. Schieffelin JS and Jacob ST. Raising the Standard for Clinical Care of Patients with Ebola virus disease. Lancet Infect Dis. 2015 Aug 10. PMID 26271407

27. Andersen KG, Shapiro BJ, Matranga CB, Sealfon R, Lin AE, Moses LM, Folarin OA, Goba A, Odia I, Ehiane PE, Momoh M, England EM, Winnicki S, Branco LM, Gire SK, Phelan E, Tariyal R, Tewhey R, Omoniwa O, Fullah M, Fonnie R, Fonnie M, Kanneh L, Jalloh S, Gbakie M, Saffa S, Karbo K, Gladden AD, Qu J, Stremlau M, Nekoui M, Finucane HK, Tabrizi S, Vitti JJ, Birren B, Fitzgerald M, McCowan C, Ireland A, Berlin AM, Bochicchio J, Tazon-Vega B, Lennon NJ, Ryan EM, Bjornson Z, Milner DA Jr, Lukens AK, Broodie N, Rowland M, Heinrich M, Akdag M, Schieffelin JS, Levy D, Akpan H, Bausch DG, Rubins K, McCormick JB, Lander ES, Günther S, Hensley L, Okogbenin S; Viral Hemorrhagic Fever Consortium, Schaffner SF, Okokhere PO, Khan SH, Grant DS, Akpede GO, Asogun DA, Gnirke A, Levin JZ, Happi CT, Garry RF, Sabeti PC. Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus. Cell. 2015; 162(4):738-50. PMID: 26276630

28. Schieffelin JS, Moses LM, Shaffer J, Goba A, Grant DS. Clinical validation trial of a diagnostic for Ebola Zaire antigen detection: design rationale and challenges to implementation. Clinical Trials.

2016; Jan 14. PMID:26768566.

29. Robinson JE, Hastie KM, Cross RW, Yenni RE, Elliott DH, Rouelle JA, Kannadka CB, Smira AA, Garry CE, Bradley BT, Yu H, Shaffer JG, Boisen ML, Hartnett JN, Zandonatti MA, Rowland MM, Heinrich ML, Martinez-Sobrido L, Cheng B, de la Torre JC, Andernsen KG, Goba A, Momoh M, Fullah M, Gbakie M, Kanneh L, Koromoa VJ, Fonnie R, Jalloh SC, Kargbo B, Vandi MA, Gbetuwa M, Ikponmwosa O, Asogun DA, Okokhere PO, Follarin OA, Schieffelin JS, Pitts KR, Geisbert JB, Kulakoski PC, Wilson RB, Happi CT, Sabeti PC, Gevao SM, Khan SH, Grant DS, Geisbert TW, Saphire EO, Branco LM, Garry RF. Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits. Nat Commun. 2016; May 10. PMID:27161536.

30. Yozwiak NL, Happi CT, Grant DS, Schieffelin JS, Garry RF, Sabeti PC, Andersen KG. Roots, Not Parachutes: Research Collaborations Combat Outbreaks. Cell. 2016; 166(1):5-8, PMID:27368093.

31. Goba A, Khan SH, Fonnie M, Fullah M, Moigboi A, Kovoma A, Sinnah V, Yoko N, Rogers H, Safai S, Momoh M, Koroma V, Kamara FK, Konowu E, Yillah M, French I, Mustapha I, Kanneh F, Foday M, McCarthy H, Kallon T, Kallon M, Naiebu J, Sellu J, Jalloh AA, Gbakie M, Kanneh L, Massaly JL, Kargbo D, Kargbo B, Vandi M, Gbetuwa M, Gevao SM, Sandi JD, Jalloh SC, Grant DS, Blyden SO, Crozier I, Schieffelin JS, McLellan SL, Jacob ST, Boisen ML, Hartnett JN, Cross RW, Branco LM, Andersen KG, Yozwiak NL, Gire SK, Tariyal R, Park DJ, Haislip AM, Bishop CM, Melnik LI, Gallaher WR, Wimley WC, He J, Shaffer JG, Sullivan BM, Grillo S, Oman S, Garry CE, Edwards DR, McCormick SJ, Elliott DH, Rouelle JA, Kannadka CB, Reyna AA, Bradley BT, Yu H, Yenni RE, Hastie KM, Geisbert JB, Kulakosky PC, Wilson RB, Oldstone MB, Pitts KR, Henderson LA, Robinson JE, Geisbert TW, Saphire EO, Happi CT, Asogun DA, Sabeti PC, Garry RF; Viral Hemorrhagic Fever Consortium. An Outbreak of Ebola Virus Disease in the Lassa Fever Zone. J Infect Dis. 2016 Jul 11. PMID: 27402779

32. Leligdowicz A, Fischer WA 2nd, Uyeki TM, Fletcher TE, Adhikari NK, Portella G, Lamontagne F, Clement C, Jacob ST, Rubinson L, Vanderschuren A, Hajek J, Murthy S, Ferri M, Crozier I, Ibrahima E, Lamah MC, Schieffelin JS, Brett-Major D, Bausch DG, Shindo N, Chan AK, O'Dempsey T, Mishra S, Jacobs M, Dickson S, Lyon GM 3rd, Fowler RA. Ebola virus disease and critical illness. Crit Care. 2016 Jul 29;20(1):217. PMID: 27468829

33. Boisen ML, Cross RW, Hartnett JN, Goba A, Momoh M, Fullah

M, Gbakie M, Safa S, Fonnie M, Baimba F, Koroma VJ, Geisbert JB, McCormick S, Nelson DK, Millett MM, Oottamasathien D, Jones AB, Pham H, Brown BL, Shaffer JG, Schieffelin JS, Kargbo B, Gbetuwa M, Gevao SM, Wilson RB, Pitts KR, Geisbert TW, Branco LM, Khan SH, Grant DS, Garry RF. Field Validationof the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection. J Infect Dis. 2016 Aug 11. PMID:27521365

34. Boisen ML, Hartnett JN, Goba A, Vandi MA, Grant DS, Schieffelin JS, Garry RF, Branco LM. Epidemiology and Management of the 2013-16 West African Ebola Outbreak. Annu Rev Virol. 2016 Aug 15. PMID: 27578439

35. Cross RW, Boisen ML, Millett MM, Nelson DS, Oottamasathien D, Hartnett JN, Jones AB, Goba A, Momoh M, Fullah M, Bornholdt ZA, Fusco ML, Abelson DM, Oda S, Brown BL, Pham H, Rowland MM, Agans KN, Geisbert JB, Heinrich ML, Kulakosky PC, Shaffer JG, Schieffelin JS, Kargbo B, Gbetuwa M, Gevao SM, Wilson RB, Saphire EO, Pitts KR, Khan SH, Grant DS, Geisbert TW, Branco LM, Garry RF. Analytical Validation of the ReEBOV Antigen Rapid Test for Ppoint-of-Care Diagnosis of Ebola Virus Infection. J Infect Dis. 2016 Aug 31. PMID: 27587634

36. Lo Iacono GL, Cunningham AA, Fichet-Calvet E, Garry RF, Grant DS, Leach M, Moses LM, Nichols G, Schieffelin JS, Shaffer JG, Webb CT, Wood JLN. A Unified Framework for the Infection Dynamics of Zoonotic Spillover and Spread. PLoS Negl Trop Dis. 2016 Sep 2;10(9):e0004957. PMID: 27588425

37. Dudas G, Carvalho LM, Bedford T, Tatem AJ, Baele G, Faria NR, Park DJ, Ladner JT, Arias A, Asogun D, Bielejec F, Caddy SL, Cotten M, D'Ambrozio J, Dellicour S, Caro AD, Diclaro JW, Duraffour S, Elmore MJ, Fakoli LS, Faye O, Gilbert ML, Gevao SM, Gire S, Gladden-Young A, Gnirke A, Goba A, Grant DS, Haagmans BL, Hiscox JA, Jah U, Kugelman JR, Liu D, Lu J, Malboeuf CM, Mate S, Matthews DA, Matranga CB, Meredith LW, Qu J, Quick J, Pas SD, Phan MV, Pollakis G, Reusken CB, Sanchez-Lockhart M, Schaffner SF, Schieffelin JS, Sealfon RS, Simon-Loriere E, Smits SL, Stoecker K, Thorne L, Tobin EA, Vandi MA, Watson SJ, West K, Whitmer S, Wiley MR, Winnicki SM, Wohl S, Wölfel R, Yozwiak NL, Andersen KG, Blyden SO, Bolay F, Carroll MW, Dahn B, Diallo B, Formenty P, Fraser C, Gao GF, Garry RF, Goodfellow I, Günther S, Happi CT, Holmes EC, Kargbo B, Keïta S, Kellam P, Koopmans MP, Kuhn JH, Loman NJ, Magassouba N, Naidoo D, Nichol ST, Nyenswah T, Palacios G, Pybus OG, Sabeti PC, Sall A, Ströher U, Wurie I, Suchard MA, Lemey P, Rambaut A. Virus Genomes Reveal Factors that Spread and Sustained the Ebola Epidemic. Nature. 2017 Apr 12. PMID: 28405027

38.

Chapters:

1. Schieffelin JS and Oberhelman RA. Ascariasis. In Rudolph CD, Rudolph AM, Lister GE, First L and Gershon AA (Eds.). Rudolph’s Pediatrics, 22nd Edition, McGraw Hill Medical, New York (2011).

2. Schieffelin JS and Oberhelman RA. Baylisascariasis In Rudolph CD, Rudolph AM, Lister GE, First L and Gershon AA (Eds.). Rudolph’s Pediatrics, 22nd Edition, McGraw Hill Medical, New York (2011).

3. Schieffelin JS and Oberhelman RA. Dracunculiasis. In Rudolph CD, Rudolph AM, Lister GE, First L and Gershon AA (Eds.). Rudolph’s Pediatrics, 22nd Edition, McGraw Hill Medical, New York (2011).

4. Schieffelin JS and Oberhelman RA. Tricuriasis. In Rudolph CD, Rudolph AM, Lister GE, First L and Gershon AA (Eds.). Rudolph’s Pediatrics, 22nd Edition, McGraw Hill Medical, New York (2011).

5. Grant DS, Khan H, Schieffelin JS and Bausch DG. Lassa Fever. In Ergonul O, Can F Madoff L and Akova M (Eds.). Emerging Infectious Diseases Clinical Case Studies, Academic Press, Waltham, MA (2014).

6. Schieffelin JS. Lassa fever. In: UpToDate, Hirsch MS (Ed), UpToDate, Waltham, MA. September 15, 2016.

Abstracts:1. Schieffelin JS, Garcia-Diaz JB and *Loss G. Dematiaceous fungal

infections in solid organ transplant recipients. World Transplant Congress, Boston, MA, 2006.

2. *Schieffelin JS, Torrellas M, Kurukularatne C et al. How natural disasters change natural patterns: coccidioidomycosis in New Orleans. 45th Infectious Disease Society of America Annual Meeting, San Diego, CA, 2007.

3. *Schieffelin JS, Costin JM, Michael SF and Robinson JE. Human monoclonal antibodies against dengue virus. 48th ICAAC/46th IDSA Annual Meeting, Washington D.C. 2008 (Abstract #V-1655).

4. *Beckman EN, Garcia-Diaz JB, Loss GE, Schieffelin JS, Staffeld-Coit CG, Garces JC, Keller RA, Pankey GA. Phaeohyphomycosis infection in solid organ transplant recipients – the largest single institution experience. 98th Annual Meeting of the United States and Canadian Academy of Pathology, 2009 (Abstract #188).

5. *Bazzone LE, Schieffelin JS, Robinson JE. The Role of Antibodies in Neutralization and Enhancement of Dengue Virus Pathogenesis. 111th

General meeting American Society of Microbiology, New Orleans, LA, 2011 (Abstract #1665).

6. *Bazzone LE, Schieffelin JS, Robinson JE. The Roles of Antibodies in Dengue Virus Pathogenesis: Understanding Protection Versus Enhancement. 60th Annual meeting of the American Society of Tropical Medicine and Hygiene, Philadelphia, PA, 2011 (Abstract #508)

7. Bond N, Schieffelin JS, Moses LM, Bennett AJ, Fritz L, Bausch DG. A Historical Look at the First Reported Cases of Lassa Fever: IgG Antibodies 40 Years After Acute Infection. 61st Annual Meeting of the American Society of Tropical Medicine and Hygiene, Atlanta, GA, 2012 (Oral Abstract #48)

8. Bazzone LE, Schieffelin JS, Robinson JE. The Effect of Antibodies on Endothelial Cells During Dengue Virus Infection. 61st Annual Meeting of the American Society of Tropical Medicine and Hygiene, Atlanta, GA, 2012 (Abstract #1085)

9. Grant DS, Goba A, Shaffer JG, Boisen ML, Branco LM, Ottomassathien D, Levy D, Bausch DG, Garry RF, Schieffelin JS. Demographic and Clinical Risk Factors for Lassa Fever in Sierra Leone. 61st Annual Meeting of the American Society of Tropical Medicine and Hygiene, Atlanta, GA, 2012 (Abstract #1275)

10. Boisen ML, Branco LM, Shaffer JG, Ottomassathien D, Jones A, Goba A, Schieffelin JS, Garry RF, Grant DS. Fevers of Unknown Origin in a Cohort of Patients Presenting to Kenema Government Hospital, Sierra Leone Suspected of Lassa Fever Infection. 61st Annual Meeting of the American Society of Tropical Medicine and Hygiene, Atlanta, GA, 2012 (Abstract #LB-245)

11. *Shaffer JG, Grant DS, Goba A, Boisen ML, Branco LM, Ottomassathien D, Levy D, Garry RF, Schieffelin JS. Epidemiology of Lassa Fever in Post-Conflict Sierra Leone: Seasonal Demographics. 11th ASM Biodefense and Emerging Diseases Research Meeting, Washington DC, 2013 (Abstract #196)

12. *Schieffelin JS, Grant D, Shaffer J, Boisen M, Branco L, Goba A, Fonnie M, Ottomassathien D, Levy D, Bausch D, Garry R. Efficacy of Ribavirin Therapy in Lassa Fever. 11th ASM Biodefense and Emerging Diseases Research Meeting, Washington DC, 2013 (Abstract #217)

13. *Boisen ML, Ottomassathien D, Branco L, Shaffer J, Jones A, Goba A, Schieffelin JS, Grant D, Garry R. Improved Detection and Surveillance of Lassa Fever in West Africa using ReLASV LF Diagnostic Assays. 11th ASM Biodefense and Emerging Diseases Research Meeting, Washington DC, 2013 (Abstract #232)

14. *Grant DS, Schieffelin JS, Shaffer JG, Boisen ML, Branco LM, Goba A, Fonnie M, Ottomassathien D, Levy D, Bausch DG, Garry RF. Efficacy of Ribavirin Therapy in Lassa Fever. 5th Sierra Leone Health and Biomedical Research Association Symposium, Freetown, Sierra Leone, 2013

15. *Goba A, Shaffer JG, Grant DS, Boisen ML, Branco LM, Ottomassathien D, Levy D, Garry RF, Schieffelin JS. Epidemiology of Lassa Fever in Post-Conflict Sierra Leone: Seasonal Demographics. 5th Sierra Leone Health and Biomedical Research Association Symposium, Freetown, Sierra Leone, 2013

16. Roth PJ, Grant D, Ngegbai AS, Schieffelin JS, *Jarrett O. Retrospective Review of Etiologies of Fever Presenting to Kenema Government Hospital in Sierra Leone. 5th Sierra Leone Health and Biomedical Research Association Symposium, Freetown, Sierra Leone, 2013

17. Boisen M, Oottamasathien D, Jones A, Millett M, Nelson J, Bornholdt Z, Fusco M, Abelson D, Oda S, Hartnett J, Rowland M, Heinrich M, Akdag M, Goba A, Momoh M, Fullah M, Baimba F, Gbakie M, Safa S, Fonnie R, Kanneh L, Cross R, Geisbert J, Geisbert T, Kulakosky P, Grant D, Shaffer J, Schieffelin J, Wilson R, Saphire E, Branco L, Garry R, Khan S, Pitts K, and the viral hemorrhagic fever consortium. Development of prototype filovirus recombinant antigen immunoassays. Targeting Ebola 2015, Paris, France, 2014.

18. Schieffelin JS*, Bazone L, Kahle K, Isern S, Doranz B, Robinson JE, Michael SF. Analysis of Clonal Lineages of Dengue Virus Envelope Protein Specific Antibodies from a Single Patient. 64th Annual meeting of the American Society of Tropical Medicine and Hygiene, Philadelphia, PA, 2015 (Abstract #176).

19. Schieffelin JS*, Bazone L, Robinson JE. Enhancing Anti-Dengue Virus Antibodies Targeting the Fusion Loop Delay and Upregulate Pro-Inflammatory Cytokine Production by FcγR-bearing Cells in vitro. 64th Annual meeting of the American Society of Tropical Medicine and Hygiene, Philadelphia, PA, 2015 (Abstract #763)

20. Schieffelin JS*, Grant DS, Shaffer JG, Kamara F, Krousel-Wood M, Garry RF. Reproductive Health Among Female Ebola Survivors. 2016 Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) Symposium. Bethesda, MD, June 7, 2016.

*Presented